News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

DEVANG PATEL, MD

Advertisement

Articles by DEVANG PATEL, MD

New Initiatives for HIV Taking Off This Year

ByJENNIFER BAILEY, PHARMD,MARY BANOUB, PHARMD,DEVANG PATEL, MD
February 15th 2018

Advances in antiretroviral therapies increase opportunities for patients with HIV to have more successful treatment outcomes.

Advertisement

Latest Updated Articles

  • New Initiatives for HIV Taking Off This Year
    New Initiatives for HIV Taking Off This Year

    Published: February 15th 2018 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Nearly 1 in 5 Urinary Tract Infections in Southern California Linked to Contaminated Meat

2

Moderna Discontinues Development of Vaccine for Congenital CMV After Not Meeting Primary Efficacy Endpoint

3

High Continued Adherence of Lenacapavir in Individuals Who Use Substances and Alcohol

4

Risk Stratification, Testing, and Treatment in Recurrent Clostridioides difficile

5

Meet SIDP’s President Elect: Lisa Dumkow, PharmD, FIDP, BCIDP

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us